Search Results (2)

Ptaeroxylon obliquum (Thunb.) Radlk. (Rutaceae) is traditionally used for a range of purposes, including ethnoveterinary medicine and to treat various human ailments such as tuberculosis, inflammatory diseases, and bacterial and fungal infections. This review aims to comprehensively summarize the traditional uses, phytochemistry, toxicology, in silico, and pharmacological activities of P. obliquum and discuss the advances made to date. The phytochemistry of P. obliquum revealed the abundance of secondary metabolites such as coumarins and chromones, essential oils, and several other classes of bioactive compounds. A total of 80 secondary metabolites have been reported from this plant species. In vitro studies on P. obliquum explored its therapeutic potential and reported pharmacological properties such as antifungal, antibacterial, antiparasitic, antimycobacterial, anti-inflammatory, and antiproliferative activities. This review highlights the diversity of the medicinal use of P. obliquum and encourages its preservation. Future research should focus on the efficacy of P. obliquum’s most promising bioactive compounds, and the ADME (absorption, distribution, metabolism, and excretion) pharmacological activities may help determine therapeutic potential in in vivo animal models and validate the wide range of traditional uses of P. obliquum. Full article

Several cancers are induced by microbial infections or chronic inflammation. Ptaeroxylon obliquum is traditionally used to treat various infections characterized by inflammation. The in vitro antiproliferative and antioxidant activity of P. obliquum leaf extracts, fractions and isolated compounds were determined. Antiproliferative activity was assessed against normal Vero cells, and several cancerous human cells, including human breast cancer (MCF-7), hepatocarcinoma (HepG2), lung adenocarcinoma (A549) and human cervical cancer cells (HeLa) using a colorimetric tetrazolium bromide assay. Radical scavenging activity was tested using the 2,2-diphenyl-1-instrpicrylhydrazyl (DPPH) and 2,2’-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assays. Obliquumol, O-methylalloptaeroxylin and a mixture of lupeol and β-amyrin were isolated from the chloroform fraction using silica gel open column chromatography. Acetone extracts were toxic to HepG2 cells with IC₅₀ values from 8 to 200 µg/mL but were less toxic to other cells with selectivity index as high as 14. Aqueous extracts and fractions were non-toxic at concentrations tested against all the cell lines (IC₅₀ > 100 µg/mL). Isolated compounds had IC₅₀ values ranging from 52 to 539 µg/mL and 189 to 247 µg/mL against HepG2 and HeLa cells, respectively. Light microscopy showing changes in HepG2 and HeLa cell morphology supported the cytotoxicity of the acetone extracts. Water extracts scavenged ABTS and DPPH radicals with IC₅₀ values as low as 29.06 µg/mL and 43.4 µg/mL. P. obliquum extracts may be useful as sources of anticancer therapy, as they have selective cytotoxicity against cancer cell lines. Full article